» Articles » PMID: 32934669

The Role of Reactive Oxygen Species in Cognitive Impairment Associated with Sleep Apnea

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2020 Sep 16
PMID 32934669
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Obstructive sleep apnea (OSA), a common breathing and sleeping disorder, is associated with a broad range of neurocognitive difficulties. Intermittent hypoxia (IH), one major characteristic of OSA, has been shown to impair learning and memory due to increased levels of reactive oxygen species (ROS). Under normal conditions, ROS are produced in low concentrations and act as signaling molecules in different processes. However, IH treatment leads to elevated ROS production via multiple pathways, including mitochondrial electron transport chain dysfunction and in particular complex I dysfunction, and induces oxidative tissue damage. Moreover, elevated ROS results in the accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER) and increased activity of peroxisomes, such as NADPH oxidase, xanthine oxidase and phospholipase A2. Furthermore, oxidative tissue damage has been found in regions of the brains of patients with OSA, including the cortex and hippocampus, which are associated with memory and executive function. Furthermore, increased ROS levels in these regions of the brain induce damage via inflammation, apoptosis, ER stress and neuronal activity disturbance. The present review focuses on the mechanism of excessive ROS production in an OSA model and the relationship between ROS and cognitive impairment.

Citing Articles

Cerebral oxidative stress, inflammation and apoptosis induced by intermittent hypoxia: a systematic review and meta-analysis of rodent data.

El Amine B, Fournier J, Minoves M, Baillieul S, Roche F, Perek N Eur Respir Rev. 2024; 33(174).

PMID: 39694586 PMC: 11653198. DOI: 10.1183/16000617.0162-2024.


Role of Oxidative Stress in the Occurrence and Development of Cognitive Dysfunction in Patients with Obstructive Sleep Apnea Syndrome.

Zhang X, Zhou H, Liu H, Xu P Mol Neurobiol. 2023; 61(8):5083-5101.

PMID: 38159196 DOI: 10.1007/s12035-023-03899-3.


Summary of drug therapy to treat cognitive impairment-induced obstructive sleep apnea.

He D, Chen J, Du X, Xu L Front Cell Neurosci. 2023; 17:1222626.

PMID: 37731463 PMC: 10507626. DOI: 10.3389/fncel.2023.1222626.


Can we obtain a reliable marker that shows the hypoxic burden in patients with sleep disordered breathing?.

Ando S Hypertens Res. 2023; 46(11):2500-2502.

PMID: 37673960 DOI: 10.1038/s41440-023-01425-5.


Relationship between acute glucose variability and cognitive decline in type 2 diabetes: A systematic review and meta-analysis.

Chi H, Song M, Zhang J, Zhou J, Liu D PLoS One. 2023; 18(9):e0289782.

PMID: 37656693 PMC: 10473499. DOI: 10.1371/journal.pone.0289782.


References
1.
Nosyreva E, Kavalali E . Activity-dependent augmentation of spontaneous neurotransmission during endoplasmic reticulum stress. J Neurosci. 2010; 30(21):7358-68. PMC: 2892630. DOI: 10.1523/JNEUROSCI.5358-09.2010. View

2.
da Rosa D, Forgiarini L, Barbachan E Silva M, Fiori C, Andrade C, Martinez D . Antioxidants inhibit the inflammatory and apoptotic processes in an intermittent hypoxia model of sleep apnea. Inflamm Res. 2014; 64(1):21-9. DOI: 10.1007/s00011-014-0778-5. View

3.
Arai K, Ikegaya Y, Nakatani Y, Kudo I, Nishiyama N, Matsuki N . Phospholipase A2 mediates ischemic injury in the hippocampus: a regional difference of neuronal vulnerability. Eur J Neurosci. 2001; 13(12):2319-23. DOI: 10.1046/j.0953-816x.2001.01623.x. View

4.
Nanduri J, Vaddi D, Khan S, Wang N, Makerenko V, Prabhakar N . Xanthine oxidase mediates hypoxia-inducible factor-2α degradation by intermittent hypoxia. PLoS One. 2013; 8(10):e75838. PMC: 3790816. DOI: 10.1371/journal.pone.0075838. View

5.
Pan W, Kastin A . Can sleep apnea cause Alzheimer's disease?. Neurosci Biobehav Rev. 2014; 47:656-69. DOI: 10.1016/j.neubiorev.2014.10.019. View